APP will launch Clonidine Hydrochloride
Injection immediately and market the analgesic in 1000 mcg/10 ml and 5000 mcg/10 ml single dose vials.
Important Information About Clonidine HCl ER Tablets Clonidine hydrochloride
extended-release tablets are contraindicated in patients with a known hypersensitivity to clonidine.
CloniBID is a 12-hour, sustained-release formulation of clonidine hydrochloride
CloniBID and Clonicel are both 12-hour, sustained-release formulations of clonidine hydrochloride
1% gel formulation of clonidine hydrochloride
for topical administration.
In July 2007, Sciele signed an exclusive licensing agreement with Addrenex to market a sustained-release formulation of clonidine hydrochloride
for the treatment of ADHD and hypertension.
The extended-release version of clonidine hydrochloride
found in KAPVAY(TM) offers an exciting new treatment option for children and adolescents with ADHD who are not experiencing adequate symptom relief from stimulants alone.
Food & Drug Administration (FDA), CLONICEL[R], a patented, sustained-release formulation of clonidine hydrochloride
for the treatment of hypertension and attention deficit and hyperactivity disorder in North America.
KAPVAY(TM) is the only formulation of clonidine hydrochloride
approved by the FDA for the treatment of ADHD, and is the first and only FDA-approved ADHD treatment indicated for use as add-on therapy to stimulant medication.
The Bertek sales force will add Zagam(R) to its current product portfolio which includes Maxzide(R), a once-a-day triamterene hydrochlorothiazide diuretic, Nitrek(R), a nitroglycerin transdermal patch system, and Clorpres(TM), a combination of clonidine hydrochloride
Clonicel is a patented extended-release formulation of clonidine hydrochloride
, a drug currently approved for hypertension.
The current study of 200 children with ADHD is the second phase 3 trial in a year to investigate the safety and efficacy of Clonicel, a long-acting version of clonidine hydrochloride